Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year . No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased
Digestive Diseases and Sciences – Springer Journals
Published: Jun 4, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera